Ticker Details
Olema Pharmaceuticals, Inc.
IPO Date:	November 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.45B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.52 | 3.91%
Avg Daily Range (30 D):	$0.59 | 3.70%
Avg Daily Range (90 D):	$0.75 | 3.27%

Institutional Daily Volume
Avg Daily Volume:	.62M
Avg Daily Volume (30 D):	1.56M
Avg Daily Volume (90 D):	1.55M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	1,151
Avg Institutional Trade:	$1.98M
Avg Institutional Trade (30 D):	$2.85M
Avg Institutional Trade (90 D):	$2.64M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.65M
Avg Closing Trade (30 D):	$5.02M
Avg Closing Trade (90 D):	$4.97M
Avg Closing Volume:	177.76K

News

Mar 16, 2026 @ 11:00 AM Olema Oncology Reports Fourth Quarter and Full Yea... Source: Na

Mar 9, 2026 @ 5:57 PM Olema Pharmaceuticals, Inc. Investigated on Behalf... Source: Business Wire

Jan 9, 2026 @ 4:08 PM Olema Insider Sells $8 Million in Shares After 300... Source: Jonathan Ponciano

Nov 18, 2025 @ 9:51 PM Olema Oncology Announces Proposed Public Offering ... Source: Courtney O'Konek

Nov 18, 2025 @ 5:01 PM Pharma Bro Martin Shkreli Shorts Olema Pharmaceuti... Source: Erica Kollmann

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.87	$-.51	$-1.87
Diluted EPS	$-1.87	$-.51	$-1.87
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-162.45M	$-46.06M	$-162.45M
Operating Income / Loss	$-178.7M	$-50.08M	$-178.7M
Cost of Revenue
Net Cash Flow	$-91.18M	$13.04M	$-91.18M
PE Ratio